Suppr超能文献

世界卫生组织 1973 年的分级分类系统是 T1 非肌肉浸润性膀胱癌的重要预后指标。

The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.

机构信息

Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Department of Urology, VU University Medical Centre, Amsterdam, The Netherlands.

出版信息

BJU Int. 2018 Dec;122(6):978-985. doi: 10.1111/bju.14238. Epub 2018 Apr 27.

Abstract

OBJECTIVES

To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 classification systems for grade in T1 bladder cancer (T1-BC), as both are currently recommended in international guidelines.

PATIENTS AND METHODS

Three uro-pathologists re-revised slides of 601 primary (first diagnosis) T1-BCs, initially managed conservatively (bacille Calmette-Guérin) in four hospitals. Grade was defined according to WHO1973 (Grade 1-3) and WHO2004 (low-grade [LG] and high-grade [HG]). This resulted in a lack of Grade 1 tumours, 188 (31%) Grade 2, and 413 (69%) Grade 3 tumours. There were 47 LG (8%) vs 554 (92%) HG tumours. We determined the prognostic value for progression-free survival (PFS) and cancer-specific survival (CSS) in Cox-regression models and corrected for age, sex, multiplicity, size and concomitant carcinoma in situ.

RESULTS

At a median follow-up of 5.9 years, 148 patients showed progression and 94 died from BC. The WHO1973 Grade 3 was negatively associated with PFS (hazard ratio [HR] 2.1) and CSS (HR 3.4), whilst WHO2004 grade was not prognostic. On multivariable analysis, WHO1973 grade was the only prognostic factor for progression (HR 2.0). Grade 3 tumours (HR 3.0), older age (HR 1.03) and tumour size >3 cm (HR 1.8) were all independently associated with worse CSS.

CONCLUSION

The WHO1973 classification system for grade has strong prognostic value in T1-BC, compared to the WHO2004 system. Our present results suggest that WHO1973 grade cannot be replaced by the WHO2004 classification in non-muscle-invasive BC guidelines.

摘要

目的

比较世界卫生组织(WHO)1973 年和 2004 年分级系统在 T1 膀胱癌(T1-BC)中的预后价值,因为这两个系统目前都被国际指南推荐。

患者和方法

三位泌尿科病理学家重新审查了四家医院的 601 例原发性(首次诊断)T1-BC 的幻灯片,这些患者最初接受卡介苗保守治疗。根据 WHO1973 年(1-3 级)和 WHO2004 年(低级别[LG]和高级别[HG])标准定义分级。结果导致 1 级肿瘤缺乏,188 例(31%)为 2 级,413 例(69%)为 3 级肿瘤。LG 肿瘤有 47 例(8%),HG 肿瘤有 554 例(92%)。我们在 Cox 回归模型中确定了无进展生存(PFS)和癌症特异性生存(CSS)的预后价值,并校正了年龄、性别、多发性、大小和同时原位癌。

结果

在中位随访 5.9 年后,148 例患者出现进展,94 例患者死于膀胱癌。WHO1973 分级 3 级与 PFS(风险比[HR]2.1)和 CSS(HR3.4)呈负相关,而 WHO2004 分级无预后意义。多变量分析显示,WHO1973 分级是进展的唯一预后因素(HR2.0)。3 级肿瘤(HR3.0)、年龄较大(HR1.03)和肿瘤大小>3cm(HR1.8)均与 CSS 较差独立相关。

结论

与 WHO2004 分级系统相比,WHO1973 分级系统在 T1-BC 中具有较强的预后价值。我们目前的结果表明,在非肌肉浸润性膀胱癌指南中,WHO1973 分级不能被 WHO2004 分类取代。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验